These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Radioactivity profiles obtained by longitudinal scanning of the whole body. Value in the postoperative supervision of thyroid cancers]. Massin JP, Thomopoulos P, Karam J, Savoie JC. J Radiol Electrol Med Nucl; 1971 May; 52(8):501-10. PubMed ID: 5116268 [No Abstract] [Full Text] [Related]
3. Is it the blood background? Chandra R, Hernberg J, Braunstein P, Dworkin HJ, Meeigan JW. J Nucl Med; 1971 Sep; 12(9):650-2. PubMed ID: 5571893 [No Abstract] [Full Text] [Related]
4. [Detection and treatment of thyroid cancer metastases with iodine-131]. Swyngedauw J, Madelain M, Rohart J, Lequint A. Lille Med; 1971 Sep; 16(6):826-34. PubMed ID: 5112242 [No Abstract] [Full Text] [Related]
5. The evaluation of metastatic thyroid carcinoma with technetium-99m pertechnetate. Sodee DB. Radiology; 1967 Jan; 88(1):145-7. PubMed ID: 6015610 [No Abstract] [Full Text] [Related]
6. [On the diagnosis and treatment of diseases of the thyroid gland with radioactive iodine]. Egorov PI, Tsfasman AZ. Ter Arkh; 1967 Mar; 39(3):5-9. PubMed ID: 4894050 [No Abstract] [Full Text] [Related]
8. [On the diagnostic and therapeutic use of I-131 in cancer of the thyroid gland]. Papalia D, Casale P, Vigneri R, Motta L. Folia Endocrinol; 1966 Aug; 19(4):483-501. PubMed ID: 6014456 [No Abstract] [Full Text] [Related]
9. An unusual site of radioiodine concentration in a patient with thyroid cancer. Ganatra RD, Atmaram SH, Sharma SM. J Nucl Med; 1972 Oct; 13(10):777. PubMed ID: 5056697 [No Abstract] [Full Text] [Related]
13. [The semiological value of scintiscanning with I-131 in the study of thyroid carcinoma. Physiopathological and clinical considerations]. Leggeri A, Bertolotti A, Daniele GM. Policlinico Chir; 1968 Jul 09; 75(6):332-51. PubMed ID: 5703903 [No Abstract] [Full Text] [Related]
14. Whole-body scanning and 131 I therapy in the management of thyroid carcinoma. Henk JM, Kirkman S, Owen GM. Br J Radiol; 1972 May 09; 45(533):369-76. PubMed ID: 4623428 [No Abstract] [Full Text] [Related]
15. [Radioisotope scanning in the diagnosis of cancer]. Kakei H. Gan No Rinsho; 1968 Apr 09; 14(4):298-301. PubMed ID: 4300315 [No Abstract] [Full Text] [Related]
16. [Diagnosis and treatment of tumors of the thyroid body. Role of radioactive iodine]. Naulleau J. Sem Hop; 1965 Oct 26; 41(44):2533-5. PubMed ID: 4285196 [No Abstract] [Full Text] [Related]
17. [Isotope diagnosis and isotope therapy of thyroid diseases]. Riccabona G. Wien Klin Wochenschr; 1968 Sep 20; 80(38):701-7. PubMed ID: 5703596 [No Abstract] [Full Text] [Related]
18. A kinetic study of [131I] iodide and [99mTc] pertechnetate in thyroid carcinoma to explain a scan discrepancy: case report. O'Connor MK, Cullen MJ, Malone JF. J Nucl Med; 1977 Aug 20; 18(8):796-8. PubMed ID: 874166 [Abstract] [Full Text] [Related]
19. [The treatment of toxic adenomas of the thyroid]. Gilbert-Dreyfus. Clin Ter; 1967 Jan 31; 40(2):109-16. PubMed ID: 5600175 [No Abstract] [Full Text] [Related]
20. Early visualization of 99mTc-pertechnetate in metastatic thyroid cancer in a patient with Graves' disease. Carr HA, Temple TE, Staab EV. J Nucl Med; 1971 Jan 31; 12(1):40-2. PubMed ID: 5107457 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]